It may not be fully effective if opened and not used within 8 hours
They are typically prescribed as part of a comprehensive weight management plan that includes lifestyle changes such as balanced nutrition, regular physical activity, and ongoing medical support
Product Specifications Compound: AOD-9604 Class: Synthetic peptide fragment / growth hormone C-terminal analog Origin: C-terminal fragment of human growth hormone (residues 177-191) with N-terminal tyrosine addition Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe Molecular Weight: ~1815 Da Form: Lyophilized powder Vial Size: 5mg in 3mL glass vial Purity: 99%+ verified by HPLC and mass spectrometry (See COAs) Research Context AOD-9604 is utilized in research applications involving peptide chemistry , growth hormone fragment research , and cellular research applications
Cool down, rinse off, hydrate
Common medical conditions we treat: Mild to moderate Asthma Attacks Minor Abdominal Pain Dizziness Ear Infections, Sinus Infections, Eye Problems, Sore Throats Urinary Tract Infections Upper Respiratory Infections, Allergies, Coughs, Colds, Flu Cuts, Abrasions, Lacerations Muscle Sprains, Strains, Deep Contusions, and Broken Bones Sports Injuries, Athlete's Foot Nausea, Diarrhea, Vomiting and other Gastro-intestinal complaints Skin Problems such as Rashes, Infections, Abscesses, Boils, Bites, and Stings Sprains, Strains & Dislocations Fractures & Broken Bones Weight Loss Program GLP-1 Injectables MinuteMed Walk In Clinic in Lafayette LA Minor Primary Care | Urgent Care | Occupational Medicine We are located at: Urgent Care & Walk In Clinic in Lafayette LA MinuteMed Walk In Clinic & Urgent Care Call (337) 534-4410 Visit 3621 Ambassador Caffery Pkwy, Suite 100, Lafayette, LA 70503 (Next to Subway) If you have a non-threatening illness and need to see an experienced health care professional immediately, contact MinuteMed Walk In Clinic Lafayette Urgent Care or come in with no appointment necessary for quality medical care and attention
Emergence of highly effective GLP-1 agonists, such as Novos semaglutide (Ozempic, Wegovy, and Rybelsus) and liraglutide (Saxenda), and Lillys tirzepatide (Mounjaro) has completely transformed the market for weight loss and diabetes 2
